Lan Cao is a highly experienced professional in the biopharmaceutical industry, currently serving as the Head of Immunology Cell Therapy Discovery at AstraZeneca. Previously, Lan held the position of Executive Director, TechOps, Technical Leader at CRISPR Therapeutics, and Vice President, Head of Chemistry, Manufacturing and Controls at Battersea Biotech. Additionally, Lan has served as Director of Process and Analytical Development at Unum Therapeutics, now known as Cogent Biosciences, demonstrating a strong background in various aspects of drug development and operational leadership.
This person is not in any teams
This person is not in any offices